Jubilant Therapeutics Inc. products

Strong scientific and clinical rationale for LSD1/HDAC6 inhibition in haematological and solid tumor.

Strong scientific and clinical rationale for novel small molecule PD-L1 inhibitor.

Strong scientific and clinical rationale for novel small molecule PRMT5 inhibitor.

Strong scientific and clinical rationale for PAD4 inhibitors in autoimmune disorders.